Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 74 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

31%

23 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

59Total
Not Applicable (23)
P 1 (1)
P 2 (12)
P 3 (13)
P 4 (10)

Trial Status

Recruiting28
Completed19
Unknown14
Not Yet Recruiting11
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT07324837Phase 3RecruitingPrimary

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

NCT06094478Not ApplicableRecruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT05892510Phase 2RecruitingPrimary

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

NCT05600374Not ApplicableRecruitingPrimary

Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

NCT07386262Not ApplicableNot Yet Recruiting

A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke

NCT07091994Phase 4Not Yet RecruitingPrimary

A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy

NCT07531394Phase 3Not Yet RecruitingPrimary

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

NCT04973332Not ApplicableCompletedPrimary

Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke

NCT06018181CompletedPrimary

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

NCT06316570Phase 3CompletedPrimary

Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke

NCT06442631Not ApplicableNot Yet Recruiting

MyStroke for Stroke Survivors and Caregivers

NCT06639360Not ApplicableRecruitingPrimary

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

NCT06196320Phase 3CompletedPrimary

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

NCT06221371Phase 3CompletedPrimary

Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion

NCT06726941Not ApplicableRecruitingPrimary

Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia

NCT07235423Not Yet RecruitingPrimary

Predictors of Post-Thrombectomy Cognitive Impairment in Acute Ischemic Stroke Patients

NCT05051397Phase 2RecruitingPrimary

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

NCT07195786Not Yet RecruitingPrimary

Expansion-floating Craniotomy for the Treatment of Malignant Cerebral Edema Caused by Acute Ischemic Stroke

NCT07175649Not ApplicableNot Yet RecruitingPrimary

Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke

NCT06075628Recruiting

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Scroll to load more

Research Network

Activity Timeline